GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.

GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.

Item
http://www.wikidata.org/entity/Q53223027
In Vivo Models for Incretin Research: From the Intestine to the Whole BodyThe Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of ObesityMicrobial regulation of GLP-1 and L-cell biologyType 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy.An Innate Disposition for a Healthier Gut: GLP-1R Signaling in Intestinal Epithelial Lymphocytes.Islet α cells and glucagon--critical regulators of energy homeostasis.GLP-1 based therapies: clinical implications for gastroenterologists.Novel approaches to treating type 2 diabetes.Incretin-based therapies: where will we be 50 years from now?GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation.Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity.Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors.The endogenous preproglucagon system is not essential for gut growth homeostasis in miceDiscovery, characterization, and clinical development of the glucagon-like peptides.Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2.Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy
P2860

GLP-1R agonists promote normal and neoplastic intestinal growth through mechanisms requiring Fgf7.

Item
http://www.wikidata.org/entity/Q53223027
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
GLP-1R agonists promote normal ...... ugh mechanisms requiring Fgf7.
@en
GLP-1R agonists promote normal ...... ugh mechanisms requiring Fgf7.
@nl
type
label
GLP-1R agonists promote normal ...... ugh mechanisms requiring Fgf7.
@en
GLP-1R agonists promote normal ...... ugh mechanisms requiring Fgf7.
@nl
prefLabel
GLP-1R agonists promote normal ...... ugh mechanisms requiring Fgf7.
@en
GLP-1R agonists promote normal ...... ugh mechanisms requiring Fgf7.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
GLP-1R agonists promote normal ...... ugh mechanisms requiring Fgf7.
@en
P2093
P304
P31
P356
10.1016/J.CMET.2015.02.005
P433
P478
P50
P577
P698